Clinical trials
Phase 1/2 Leukemia, Myeloid, Acute trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 6 |
| Terminated | 5 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 1 |
| Accenture | 1 |
| Aptose Biosciences Inc. | 1 |
| Ascentage Pharma Group Inc. | 1 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
| CRISPR Therapeutics | 1 |
| Celgene | 1 |
| Ellipses Pharma | 1 |
| Forma Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 21 |
| Myelodysplastic Syndromes | 7 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Recurrence | 4 |
| Leukemia | 3 |
| Leukemia, Myelomonocytic, Chronic | 3 |
| Leukemia, Biphenotypic, Acute | 2 |
| Multiple Myeloma | 2 |
| Hematologic Neoplasms | 1 |
| Hodgkin Disease | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.